With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

Healthcare in Pakistan
From Institutional Excellence to Population-Level Access: How Pakistan Can Bridge Its Healthcare Divide
June 1, 2026

Healthcare systems are under pressure almost everywhere, but the strain is especially visible in lower-resource settings where demand is rising faster than infrastructure. In Pakistan, that pressure is playing out across a system that has to serve more than 250 million people with limited public investment. Public health spending remains below 1% of GDP,…

Read More
Engineering
Scaling Experiential Learning in the Curriculum: How Iron Range Engineering Transformed Engineering Education
June 1, 2026

Engineering has transformed nearly every part of modern life, from the phones in our pockets to the systems powering global industry. But the way engineers are educated has often moved far more slowly than the profession itself. Employers are asking for graduates who can navigate ambiguity, communicate across teams, and contribute meaningfully from the…

Read More
vascular surgeon
When Geography Meets Purpose: How One Move Reshaped a Vascular Surgeon’s Career
May 28, 2026

Medicine isn’t what it used to be—not for the people practicing it. Independent physicians are becoming the exception, not the norm, as more doctors move into hospital systems, corporate groups, and academic networks. At the same time, the pipeline of specialists isn’t keeping pace with growing patient needs, particularly in complex fields like vascular…

Read More
safer HVAC chemicals
From Second Chances to Stronger Teams: Bradley Henderson on Structure, Culture, and Trades-Based Redemption
May 26, 2026

The trades have always demanded grit, but grit alone doesn’t build a strong workforce. People need structure, clear expectations, and a sense that their work is taking them somewhere. That’s especially true in HVAC and mechanical services, where employers are trying to hire, retain, and develop talent in a labor market that feels tighter and…

Read More